These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4553743)

  • 1. Failure of vasodilator drugs in arteriosclerosis obliterans.
    Coffman JD; Mannick JA
    Ann Intern Med; 1972 Jan; 76(1):35-9. PubMed ID: 4553743
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of vasodilator drugs on skin blood-flow in peripheral vascular occlusion. A double-blind trial using tolazoline.
    Thomas M; Campbell H; Heard G
    Br J Surg; 1968 Aug; 55(8):588-90. PubMed ID: 4874477
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of vasodilators in peripheral arterial insufficiency].
    Hansteen V; Lorentsen E
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1731-4. PubMed ID: 5111131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
    Ost CR; Sténson S
    Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of anticoagulants, vasodilators, and dipyridamole on postischemic cerebral vascular obstruction.
    Cantu RC; Snyder M
    J Surg Res; 1972 Aug; 13(2):70-1. PubMed ID: 4262552
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of Pridazol and papaverine injected into the femoral artery on the blood supply of the muscles of the lower extremities].
    Galus K
    Pol Arch Med Wewn; 1969 Jul; 43(1):1015-24. PubMed ID: 5343552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB; Ghezzi P; Cavaliere P
    Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with bencyclane in peripheral disorders of arterial blood supply].
    Alánt O; Horváth N
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1403+. PubMed ID: 5536654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
    Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress surveillance of limb artery occlusions].
    Bollinger A; Lüthy E
    Schweiz Med Wochenschr; 1966 Aug; 96(34):1094-8. PubMed ID: 5985858
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T
    Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
    [No Abstract]   [Full Text] [Related]  

  • 14. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of delayed-action Tebonin with the study of muscle flow, using xenon 133].
    Matteoni R; Reale R; Lauri D; Sirolli C; Tata MV
    Minerva Cardioangiol; 1973 Apr; 21(4):264-71. PubMed ID: 4710123
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical, oscillographic and plethysmographic comparison before and after medical and surgical treatment of subjects with peripheral obliterating arteriopathy].
    Tardito E; Grassi T
    Minerva Med; 1971 May; 62(39):1971-80. PubMed ID: 5579735
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of vasodilator drugs in the treatment of diabetic arteriosclerosis obliterans.
    MOSS JM
    J Am Geriatr Soc; 1954 May; 2(5):284-7. PubMed ID: 13162729
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans.
    Shimamoto T; Atsumi T; Yamashita S; Motomiya T; Isokane N; Ishioka T; Sakuma A
    Am Heart J; 1970 Jan; 79(1):5-19. PubMed ID: 4903137
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phonoangiographic demonstration of the effect of various vasodilators on patients with peripheral obliterans arteriosclerosis].
    Meciani L; Tealdi D; Santa A; Ricci G
    Minerva Cardioangiol; 1969 Nov; 17(11):942-7. PubMed ID: 5404822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.